$CKX
CKX LANDS, INC.

2021 Q1 Form 10-Q Financial Statement

#000143774921011298 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $154.9K $180.4K
YoY Change -14.14% 17.54%
Cost Of Revenue $9.180K $14.19K
YoY Change -35.31% -27.23%
Gross Profit $145.7K $166.2K
YoY Change -12.33% 24.05%
Gross Profit Margin 94.08% 92.13%
Selling, General & Admin $103.1K $143.1K
YoY Change -27.98% 19.23%
% of Gross Profit 70.75% 86.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $507.00 $234.00
YoY Change 116.67% -62.01%
% of Gross Profit 0.35% 0.14%
Operating Expenses $103.6K $143.4K
YoY Change -27.74% 18.92%
Operating Profit $448.3K $55.96K
YoY Change 701.23% -37.38%
Interest Expense $4.670K $17.88K
YoY Change -73.88% -32.58%
% of Operating Profit 1.04% 31.95%
Other Income/Expense, Net
YoY Change
Pretax Income $453.0K $73.83K
YoY Change 513.56% -36.29%
Income Tax $26.19K $15.45K
% Of Pretax Income 5.78% 20.92%
Net Earnings $426.8K $58.38K
YoY Change 631.06% -44.78%
Net Earnings / Revenue 275.58% 32.36%
Basic Earnings Per Share $0.22 $0.03
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.942M 1.942M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.338M $6.530M
YoY Change 12.38% 15.31%
Cash & Equivalents $6.835M $2.867M
Short-Term Investments $502.7K $3.663M
Other Short-Term Assets $137.2K $148.7K
YoY Change -7.71% -40.15%
Inventory
Prepaid Expenses
Receivables $95.14K $77.69K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.570M $6.756M
YoY Change 12.05% 13.17%
LONG-TERM ASSETS
Property, Plant & Equipment $9.126M $9.242M
YoY Change -1.25% 0.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $9.126M $9.242M
YoY Change -1.25% -4.87%
TOTAL ASSETS
Total Short-Term Assets $7.570M $6.756M
Total Long-Term Assets $9.126M $9.242M
Total Assets $16.70M $16.00M
YoY Change 4.37% 1.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $97.09K $128.3K
YoY Change -24.36% -33.93%
Accrued Expenses
YoY Change
Deferred Revenue $172.6K $167.3K
YoY Change 3.16%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $295.2K $304.4K
YoY Change -3.01% 56.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $295.2K $304.4K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $482.9K $492.0K
YoY Change -1.86% 28.83%
SHAREHOLDERS EQUITY
Retained Earnings $16.15M $15.45M
YoY Change 4.58% 1.33%
Common Stock $59.34K $59.34K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.21M $15.51M
YoY Change
Total Liabilities & Shareholders Equity $16.70M $16.00M
YoY Change 4.37% 1.99%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $426.8K $58.38K
YoY Change 631.06% -44.78%
Depreciation, Depletion And Amortization $507.00 $234.00
YoY Change 116.67% -62.01%
Cash From Operating Activities -$151.0K $21.74K
YoY Change -794.36% -154.34%
INVESTING ACTIVITIES
Capital Expenditures -$14.11K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $1.210M
YoY Change 147.48%
Cash From Investing Activities $523.1K -$434.9K
YoY Change -220.29% -242.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$151.0K 21.74K
Cash From Investing Activities $523.1K -434.9K
Cash From Financing Activities
Net Change In Cash $372.1K -413.1K
YoY Change -190.08% -255.43%
FREE CASH FLOW
Cash From Operating Activities -$151.0K $21.74K
Capital Expenditures -$14.11K $0.00
Free Cash Flow -$136.9K $21.74K
YoY Change -729.47% -137.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
14114
CY2020Q1 ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
97087
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
110786
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95135
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
98515
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
25486
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80977
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80470
CY2021Q1 us-gaap Assets
Assets
16696499
CY2020Q4 us-gaap Assets
Assets
16316697
CY2021Q1 us-gaap Assets Current
AssetsCurrent
7570488
CY2020Q4 us-gaap Assets Current
AssetsCurrent
7073076
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
14114
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9321
CY2021Q1 us-gaap Cash
Cash
6835402
CY2020Q4 us-gaap Cash
Cash
6463255
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6463255
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6835402
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2867156
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
372147
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-413133
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26186
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3280289
CY2021Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1942495
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1942495
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1942495
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1942495
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
59335
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
59335
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&nbsp;</div> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;">The Company maintains its cash balances in <div style="display: inline; font-style: italic; font: inherit;">seven</div> financial institutions. The amount on deposit in each financial institution is insured by the Federal Deposit Insurance Corporation up to <div style="display: inline; font-style: italic; font: inherit;">$250,000.</div> The Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses in such accounts and management believes the Company is <div style="display: inline; font-style: italic; font: inherit;">not</div> exposed to any significant credit risk on its cash balances.</div></div></div></div>
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
172617
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
231409
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
-293451
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
124436
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
26186
CY2020Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
15448
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
187664
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
187664
CY2021Q1 us-gaap Depletion
Depletion
77
CY2020Q1 us-gaap Depletion
Depletion
134
CY2021Q1 us-gaap Depreciation
Depreciation
507
CY2020Q1 us-gaap Depreciation
Depreciation
234
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.22
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
83854
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
502719
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
502595
CY2021Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
406220
CY2020Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
33107
CY2021Q1 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
406220
CY2020Q1 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
33107
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
103083
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
143121
CY2021Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
452993
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
73830
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2021Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
125141
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1210163
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15448
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2021Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-47005
CY2020Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
76944
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
4666
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
17875
CY2021Q1 us-gaap Liabilities
Liabilities
482854
CY2020Q4 us-gaap Liabilities
Liabilities
529859
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16696499
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16316697
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
295190
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
342195
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
523122
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-434876
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-150975
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21743
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
426807
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
58382
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
448327
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
55955
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
124
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1978
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
137232
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8711
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
744000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
537360
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
33265
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15786838
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9206988
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9324091
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9126011
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9243621
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16154310
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15727503
CY2021Q1 us-gaap Revenues
Revenues
154876
CY2020Q1 us-gaap Revenues
Revenues
180391
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
16213645
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
15447455
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15505837
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3010
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495

Files In Submission

Name View Source Status
0001437749-21-011298-index-headers.html Edgar Link pending
0001437749-21-011298-index.html Edgar Link pending
0001437749-21-011298.txt Edgar Link pending
0001437749-21-011298-xbrl.zip Edgar Link pending
ckx-20210331.xml Edgar Link completed
ckx-20210331.xsd Edgar Link pending
ckx-20210331_cal.xml Edgar Link unprocessable
ckx-20210331_def.xml Edgar Link unprocessable
ckx-20210331_lab.xml Edgar Link unprocessable
ckx-20210331_pre.xml Edgar Link unprocessable
ckx20210331_10q.htm Edgar Link pending
ex_245572.htm Edgar Link pending
ex_245573.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending